𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk factors for hepatitis B and hepatitis C infection in drug users

✍ Scribed by K.H. Lamden; N. Kennedy; N.J. Beeching; D. Lowe; C. Morrison; H. Mallison; S. Ruben; K. Mutton


Book ID
108407634
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
131 KB
Volume
36
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prevalence of hepatitis B virus and risk
✍ Renata C. Ferreira; Fabiana P. Rodrigues; Sheila A. Teles; Carmen L.R. Lopes; An πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 2 views

## Abstract Non‐injecting drug users are at high‐risk for acquiring hepatitis B virus (HBV), although the factors contributing to this increased risk are not known. In the present study, the overall and occult HBV infection prevalence rates were determined in a large population of non‐injecting dru

Hepatitis C infection among intravenous
✍ Victoria L. Demetriou; David A.M.C. van de Vijver; Johana Hezka; Leondios G. Kos πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 276 KB πŸ‘ 1 views

## Abstract The most high‐risk population for HCV transmission worldwide today are intravenous drug users. HCV genotypes in the general population in Cyprus demonstrate a polyphyletic infection and include subtypes associated with intravenous drug users. The prevalence of HCV, HBV, and HIV infectio

Hepatitis C virus infection among noninj
✍ Beryl A. Koblin; Stephanie H. Factor; Yingfeng Wu; David Vlahov πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

## Abstract The prevalence of hepatitis C virus (HCV) infection among noninjecting drug users has been reported to be higher than in the general population, but the reasons for this observation remain unclear. Noninjecting drug users aged 15–40 years and who used drugs for no longer than 10 years w